 Home > Chemicals Industry > China Chemical > Under the normalization of centralized procurement, pharmaceutical equipment will escort the production capacity and supply of pharmaceutical companies

Under the normalization of centralized procurement, pharmaceutical equipment will escort the production capacity and supply of pharmaceutical companies

 Last Update: 2021-11-08
 Source: Internet
 Author: User

Tags

ethanol production

buncher machine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Focus on Chemical Machinery and Equipment Network ] In recent years, the prices of a large number of medicines, including conventional medicines in public hospitals, are falling again and again, driven by the continuous national procurement of medicines.
But it is worth noting that while benefiting more and more patients, many pharmaceutical companies are also beginning to face more and more challenges.
Among them, the production capacity and supply stability of winning bidders in particular are being tested.

Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipment

As far as pharmaceutical companies are concerned, in fact, with the expansion of volume purchases, the demand for capacity expansion of successful bidders is expected to continue to increase.
However, in the context of centralized drug procurement and price reduction, it is also facing more and more stringent regulatory pressures in terms of production capacity and quality assurance.
Therefore, how to achieve cost control and ensure production capacity and supply stability will become a major challenge in the development of pharmaceutical companies.

Industry analysts believe that, in this context, pharmaceutical equipment will play a role in liberating more productivity, and there will be a lot to do in the future.
Therefore, with the rapid development of intelligence, automation, and informatization, the pharmaceutical equipment industry needs to grasp new trends and new technologies, and continuously optimize and upgrade, so that the equipment can achieve greater value and better provide for the production and supply of pharmaceutical companies.
Stability and escort.

Pharmaceutical equipment

It is understood that at present, domestic pharmaceutical equipment companies represented by large companies are beginning to develop and deploy new technologies in order to meet the changing requirements of pharmaceutical companies.
For example, a pharmaceutical equipment company provides innovative solutions for the continuous production of solid pharmaceuticals.
From powder to tablets and capsules, customers can flexibly develop, produce and package their products, so that the products can move from mass production to continuous production.
Production has paved the way for more efficient pharmaceutical production.

　　There are also Chinese medicine pill making machine manufacturers who choose to continuously improve and innovate around Chinese medicine pills and suppository equipment, from a single product to a complete set of equipment, and to provide a complete set of technical solutions.
At present, the company has created a fully automated production lines linked pills, large wax shell pill medicine packaging machine group, suppository filling line, high-speed automatic packaging bottling lines, automatic feeding and discharging pellets (tablets) polish coating unit, tunnel Multi-layer microwave drying sterilizers and other products provide professional pharmaceutical equipment support for the development of the Chinese medicine industry.

Packing Machine

　　From the above point of view, pharmaceutical equipment is playing an increasingly important role in the R&D and production of pharmaceutical companies.
In fact, pharmaceutical equipment is an indispensable tool and equipment for pharmaceutical production, and is the "heart" and "engine" of the pharmaceutical industry.
The performance, function and control accuracy of pharmaceutical equipment will directly affect the quality of pharmaceuticals.
Therefore, in order to better promote the development of pharmaceutical companies in the context of centralized procurement, the industry believes that the pharmaceutical equipment industry also needs continuous innovation, so as to continuously introduce new equipment to meet the higher market demand of pharmaceutical companies.

　　According to the author's understanding, in recent years, in the context of continuous advancement in science and technology, in order to improve efficiency and further guarantee the quality of medicines, more pharmaceutical equipment, as well as intelligent and fully automatic production lines are beginning to be widely used in the pharmaceutical production process.
, Some pharmaceutical companies have even begun to adopt the "machine substitution" model to achieve mechanized operations and continuously improve the quality of drug production while reducing input costs.

　　In the long run, the normalization of volume procurement will continue to be beneficial to the pharmaceutical equipment industry as a whole.
Under the background that the normalization of large-volume procurement varieties will soon benefit patients across the country, pharmaceutical companies are expected to need more high-quality pharmaceutical equipment that can escort their production capacity and supply.

　　However, in this context, combined with the current domestic pharmaceutical equipment development status, relevant pharmaceutical equipment companies need to effectively deepen cooperation with pharmaceutical companies and maintain more in-depth exchanges; at the same time, they must also strengthen R&D investment to cultivate professional talents.
To create new equipment and new technologies that are more in line with the real needs of pharmaceutical companies.
In general, only by grasping the market development trend can we achieve better development.

　　Original title: Under the normalization of centralized procurement, pharmaceutical equipment will escort the production capacity and supply of pharmaceutical companies

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.